Patient-led surveillance safe, feasible after localized melanoma treatment

Reuters Health - 10/12/2021 - It may be safe and feasible for patients treated for localized melanoma to manage surveillance for future skin lesions at home with the help of a smartphone, telemedicine assistance, and a partner to help with skin exams, a pilot study suggests. The study included 100 patients treated for localized melanoma at one of two primary skin cancer clinics in Sydney, Australia, who owned smartphones, had a partner to assist with skin self-examinations, and were compliant with attending follow-up visits. Patients were randomized 1:1 to receive usual care alone - which involved clinician-led surveillance - or in combination with a patient-led surveillance program for six months. Participants in the patient-led surveillance group received regular reminders to perform skin self-examinations, a mobile dermatoscope that could attach to their smartphone for self-dermascopy, telehealth assessments, and fast-tracked in-person appointments with a dermato...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on 10 December, 202114 December, 2021